Material Information-Announcement of Stabilization Operation Results during the First Five Trading Days after the Company’s Initial Taipei Exchange Listing
1.Date of occurrence of the event:2025/12/30
2.Company name:Handa Pharmaceuticals, Inc.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office
4.Reciprocal shareholding ratios:NA
5.Cause of occurrence:Pursuant to the ”Taiwan Securities Association Rules for Underwriters Handling Initial Listing/OTC Cases,” the Company announces the result of the price stabilization operation during the first five business days after its Taipei Exchange listing.
(1)Lead underwriter: First Securities Incorporation
(2)Name and code of securities: Handa Pharma, 6620
(3)Actual number of overallotment shares: 350,000 shares
(4)Underwriting price: NTD 84.33 per share
(5)Proceeds from overallotment: NTD 29,515,500
(6)Period of stabilization operation: December 23, 2025 ~ December 30, 2025
(7)Cumulative shares repurchased by the lead underwriter through the ”stabilization account”: 0 shares
6.Countermeasures:NA
7.Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):None